sexta-feira, maio 27, 2005
Fortovase acaba em 2006
The letter cites decreased demand for Fortovase as the reason for the product's discontinuation.Invirase, another formulation of saquinavir manufactured by Roche Pharmaceuticals, will continue to be available in 200-mg and 500-mg formulations.
Roche suggests that physicians refrain from starting Fortovase treatment in their HIV-positive Patients at this time, and encourages prescribing health care providers to discuss appropriate alternative treatment regimens with patients currently receiving Fortovase.
The complete Dear Health Care Provider letter is available at http://www.invirase.com/pdf/FTVDearDoctorFINAL.pdf